{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T07:21:19Z","timestamp":1710400879110},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s40618-014-0093-6","type":"journal-article","created":{"date-parts":[[2014,5,31]],"date-time":"2014-05-31T03:46:48Z","timestamp":1401508008000},"page":"667-673","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Subchronic olanzapine treatment decreases the expression of pancreatic glucose transporter 2 in rat pancreatic \u03b2 cells"],"prefix":"10.1007","volume":"37","author":[{"given":"Shengqiang","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dezhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,1]]},"reference":[{"issue":"1","key":"93_CR1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","volume":"36","author":"RW Buchanan","year":"2010","unstructured":"Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W (2010) The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 36(1):71\u201393. doi: 10.1093\/schbul\/sbp116","journal-title":"Schizophr Bull"},{"key":"93_CR2","doi-asserted-by":"crossref","unstructured":"Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (3):CD006654. doi: 10.1002\/14651858.CD006654.pub2","DOI":"10.1002\/14651858.CD006654.pub2"},{"issue":"18","key":"93_CR3","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2174\/1381612043384088","volume":"10","author":"J Ananth","year":"2004","unstructured":"Ananth J, Parameswaran S, Gunatilake S (2004) Side effects of atypical antipsychotic drugs. Curr Pharm Des 10(18):2219\u20132229","journal-title":"Curr Pharm Des"},{"issue":"12","key":"93_CR4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4088\/JCP.v64n1206","volume":"64","author":"CF Ebenbichler","year":"2003","unstructured":"Ebenbichler CF, Laimer M, Eder U, Mangweth B, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Patsch JR, Fleischhacker WW (2003) Olanzapine induces insulin resistance: results from a prospective study. J Clin Psychiatry 64(12):1436\u20131439","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"93_CR5","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.clinthera.2004.12.003","volume":"26","author":"JW Newcomer","year":"2004","unstructured":"Newcomer JW (2004) Metabolic risk during antipsychotic treatment. Clin Ther 26(12):1936\u20131946. doi: 10.1016\/j.clinthera.2004.12.003","journal-title":"Clin Ther"},{"issue":"Suppl 1","key":"93_CR6","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19(Suppl 1):1\u201393","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"93_CR7","first-page":"20","volume":"68","author":"JW Newcomer","year":"2007","unstructured":"Newcomer JW (2007) Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 68(Suppl 1):20\u201327","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"93_CR8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11920-009-0006-0","volume":"11","author":"JO Brooks 3rd","year":"2009","unstructured":"Brooks JO 3rd, Chang HS, Krasnykh O (2009) Metabolic risks in older adults receiving second-generation antipsychotic medication. Curr Psychiatry Rep 11(1):33\u201340","journal-title":"Curr Psychiatry Rep"},{"key":"93_CR9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0074-7696(08)62677-7","volume":"137","author":"B Thorens","year":"1992","unstructured":"Thorens B (1992) Molecular and cellular physiology of GLUT-2, a high-Km facilitated diffusion glucose transporter. Int Rev Cytol 137:209\u2013238","journal-title":"Int Rev Cytol"},{"issue":"6","key":"93_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2337\/diab.39.6.647","volume":"39","author":"FM Matschinsky","year":"1990","unstructured":"Matschinsky FM (1990) Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes 39(6):647\u2013652","journal-title":"Diabetes"},{"issue":"Pt 5","key":"93_CR11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1242\/jcs.113.5.841","volume":"113","author":"G Guillemain","year":"2000","unstructured":"Guillemain G, Loizeau M, Pincon-Raymond M, Girard J, Leturque A (2000) The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells. J Cell Sci 113(Pt 5):841\u2013847","journal-title":"J Cell Sci"},{"issue":"Pt 1","key":"93_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/bj3640201","volume":"364","author":"G Guillemain","year":"2002","unstructured":"Guillemain G, Munoz-Alonso MJ, Cassany A, Loizeau M, Faussat AM, Burnol AF, Leturque A (2002) Karyopherin alpha2: a control step of glucose-sensitive gene expression in hepatic cells. Biochem J 364(Pt 1):201\u2013209","journal-title":"Biochem J"},{"issue":"1","key":"93_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1398-9219.2003.0143.x","volume":"5","author":"A Cassany","year":"2004","unstructured":"Cassany A, Guillemain G, Klein C, Dalet V, Brot-Laroche E, Leturque A (2004) A karyopherin alpha2 nuclear transport pathway is regulated by glucose in hepatic and pancreatic cells. Traffic 5(1):10\u201319 (pii: 143)","journal-title":"Traffic"},{"issue":"3","key":"93_CR14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jcp.21245","volume":"213","author":"M Gall Le","year":"2007","unstructured":"Le Gall M, Tobin V, Stolarczyk E, Dalet V, Leturque A, Brot-Laroche E (2007) Sugar sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism. J Cell Physiol 213(3):834\u2013843. doi: 10.1002\/jcp.21245","journal-title":"J Cell Physiol"},{"issue":"Pt 1","key":"93_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/bj20031549","volume":"378","author":"G Guillemain","year":"2004","unstructured":"Guillemain G, Da Silva Xavier G, Rafiq I, Leturque A, Rutter GA (2004) Importin beta1 mediates the glucose-stimulated nuclear import of pancreatic and duodenal homeobox-1 in pancreatic islet beta-cells (MIN6). Biochem J 378(Pt 1):219\u2013227. doi: 10.1042\/BJ20031549","journal-title":"Biochem J"},{"issue":"5","key":"93_CR16","doi-asserted-by":"crossref","first-page":"E985","DOI":"10.1152\/ajpendo.00004.2009","volume":"296","author":"A Leturque","year":"2009","unstructured":"Leturque A, Brot-Laroche E, Le Gall M (2009) GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab 296(5):E985\u2013E992. doi: 10.1152\/ajpendo.00004.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6061","key":"93_CR17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1126\/science.1207154","volume":"334","author":"S Levy","year":"2011","unstructured":"Levy S, Kafri M, Carmi M, Barkai N (2011) The competitive advantage of a dual-transporter system. Science 334(6061):1408\u20131412. doi: 10.1126\/science.1207154","journal-title":"Science"},{"issue":"1","key":"93_CR18","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1371\/journal.pbio.0000020","volume":"1","author":"I Barroso","year":"2003","unstructured":"Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O\u2019Rahilly S, Wareham NJ (2003) Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1(1):E20. doi: 10.1371\/journal.pbio.0000020","journal-title":"PLoS Biol"},{"issue":"1","key":"93_CR19","doi-asserted-by":"crossref","first-page":"e15813","DOI":"10.1371\/journal.pone.0015813","volume":"6","author":"KS Burgdorf","year":"2011","unstructured":"Burgdorf KS, Grarup N, Justesen JM, Harder MN, Witte DR, Jorgensen T, Sandbaek A, Lauritzen T, Madsbad S, Hansen T, Pedersen O (2011) Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS ONE 6(1):e15813. doi: 10.1371\/journal.pone.0015813","journal-title":"PLoS ONE"},{"issue":"7","key":"93_CR20","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/diabetes.54.7.2256","volume":"54","author":"O Laukkanen","year":"2005","unstructured":"Laukkanen O, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M (2005) Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 54(7):2256\u20132260 (pii: 54\/7\/2256)","journal-title":"Diabetes"},{"issue":"5","key":"93_CR21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1210\/jcem.86.5.7499","volume":"86","author":"AM Moller","year":"2001","unstructured":"Moller AM, Jensen NM, Pildal J, Drivsholm T, Borch-Johnsen K, Urhammer SA, Hansen T, Pedersen O (2001) Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 86(5):2181\u20132186","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"93_CR22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/db06-0461","volume":"56","author":"CJ Willer","year":"2007","unstructured":"Willer CJ, Bonnycastle LL, Conneely KN, Duren WL, Jackson AU, Scott LJ, Narisu N, Chines PS, Skol A, Stringham HM, Petrie J, Erdos MR, Swift AJ, Enloe ST, Sprau AG, Smith E, Tong M, Doheny KF, Pugh EW, Watanabe RM, Buchanan TA, Valle TT, Bergman RN, Tuomilehto J, Mohlke KL, Collins FS, Boehnke M (2007) Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes. Diabetes 56(1):256\u2013264. doi: 10.2337\/db06-0461","journal-title":"Diabetes"},{"key":"93_CR23","author":"M Ikegami","year":"2013","unstructured":"Ikegami M, Ikeda H, Ishikawa Y, Ohsawa M, Ohashi T, Kai M, Kamei A, Kamei J (2013) Olanzapine induces glucose intolerance through the activation of AMPK in the mouse hypothalamus. Eur J Pharmacol. doi: 10.1016\/j.ejphar.2013.08.006","journal-title":"Eur J Pharmacol"},{"key":"93_CR24","author":"RH Schmidt","year":"2013","unstructured":"Schmidt RH, Jokinen JD, Massey VL, Falkner KC, Shi X, Yin X, Zhang X, Beier JI, Arteel GE (2013) Olanzapine activates hepatic mammalian target of rapamycin (mTOR): new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs. J Pharmacol Exp Ther. doi: 10.1124\/jpet.113.207621","journal-title":"J Pharmacol Exp Ther"},{"key":"93_CR25","unstructured":"(2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington, D.C"},{"issue":"3","key":"93_CR26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.neuropharm.2011.02.019","volume":"62","author":"HN Boyda","year":"2012","unstructured":"Boyda HN, Procyshyn RM, Tse L, Wong D, Pang CC, Honer WG, Barr AM (2012) Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats. Neuropharmacology 62(3):1391\u20131400. doi: 10.1016\/j.neuropharm.2011.02.019","journal-title":"Neuropharmacology"},{"issue":"4","key":"93_CR27","first-page":"241","volume":"37","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Wang G, Wang H (2004) Different effects of risperidone and clozapine on insulin secretion in rat islets of Langerhans in vitro. Chin J Psychiatry 37(4):241\u2013243","journal-title":"Chin J Psychiatry"},{"issue":"5","key":"93_CR28","doi-asserted-by":"crossref","first-page":"e38005","DOI":"10.1371\/journal.pone.0038005","volume":"7","author":"DS Cao","year":"2012","unstructured":"Cao DS, Zhong L, Hsieh TH, Abooj M, Bishnoi M, Hughes L, Premkumar LS (2012) Expression of transient receptor potential ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells. PLoS ONE 7(5):e38005. doi: 10.1371\/journal.pone.0038005","journal-title":"PLoS ONE"},{"issue":"9","key":"93_CR29","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/db11-0368","volume":"60","author":"K Dezaki","year":"2011","unstructured":"Dezaki K, Damdindorj B, Sone H, Dyachok O, Tengholm A, Gylfe E, Kurashina T, Yoshida M, Kakei M, Yada T (2011) Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet beta-cells. Diabetes 60(9):2315\u20132324. doi: 10.2337\/db11-0368","journal-title":"Diabetes"},{"issue":"2","key":"93_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129\u2013139. doi: 10.1056\/NEJMoa0808431","journal-title":"N Engl J Med"},{"issue":"3","key":"93_CR31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000112457","volume":"1","author":"J Levesque","year":"2008","unstructured":"Levesque J, Lamarche B (2008) The metabolic syndrome: definitions, prevalence and management. J Nutrigenet Nutrigenomics 1(3):100\u2013108. doi: 10.1159\/000112457","journal-title":"J Nutrigenet Nutrigenomics"},{"key":"93_CR32","unstructured":"Vasudevan AR, Garber AJ (2005) Insulin resistance syndrome. A review. Minerva Endocrinol 30(3):101\u2013119"},{"issue":"3","key":"93_CR33","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214\u2013E223","journal-title":"Am J Physiol"},{"issue":"7","key":"93_CR34","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85(7):2402\u20132410","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"93_CR35","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/me.2006-0473","volume":"21","author":"J Yu","year":"2007","unstructured":"Yu J, Berggren PO, Barker CJ (2007) An autocrine insulin feedback loop maintains pancreatic beta-cell 3-phosphorylated inositol lipids. Mol Endocrinol 21(11):2775\u20132784. doi: 10.1210\/me.2006-0473","journal-title":"Mol Endocrinol"},{"key":"93_CR36","unstructured":"Li X, Luo M, Li J (2004) Pancreas islet \u03b2 cell and Insulin resistance. Chin J Endocrinol Metab 20(4):4a-7"},{"issue":"20","key":"93_CR37","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.1073\/pnas.95.20.11921","volume":"95","author":"MY Wang","year":"1998","unstructured":"Wang MY, Koyama K, Shimabukuro M, Mangelsdorf D, Newgard CB, Unger RH (1998) Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion. Proc Natl Acad Sci USA 95(20):11921\u201311926","journal-title":"Proc Natl Acad Sci USA"},{"key":"93_CR38","author":"EM Girault","year":"2013","unstructured":"Girault EM, Toonen PW, Eggels L, Foppen E, Ackermans MT, la Fleur SE, Fliers E, Kalsbeek A (2013) Olanzapine-induced changes in glucose metabolism are independent of the melanin-concentrating hormone system. Psychoneuroendocrinology. doi: 10.1016\/j.psyneuen.2013.06.021","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"93_CR39","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.2337\/db10-0449","volume":"59","author":"PJ Martins","year":"2010","unstructured":"Martins PJ, Haas M, Obici S (2010) Central nervous system delivery of the antipsychotic olanzapine induces hepatic insulin resistance. Diabetes 59(10):2418\u20132425. doi: 10.2337\/db10-0449","journal-title":"Diabetes"},{"issue":"8","key":"93_CR40","doi-asserted-by":"crossref","first-page":"e43244","DOI":"10.1371\/journal.pone.0043244","volume":"7","author":"EM Girault","year":"2012","unstructured":"Girault EM, Alkemade A, Foppen E, Ackermans MT, Fliers E, Kalsbeek A (2012) Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance. PLoS ONE 7(8):e43244. doi: 10.1371\/journal.pone.0043244","journal-title":"PLoS ONE"},{"issue":"3","key":"93_CR41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/en.2007-1321","volume":"149","author":"DD Lam","year":"2008","unstructured":"Lam DD, Przydzial MJ, Ridley SH, Yeo GS, Rochford JJ, O\u2019Rahilly S, Heisler LK (2008) Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149(3):1323\u20131328. doi: 10.1210\/en.2007-1321","journal-title":"Endocrinology"},{"issue":"9","key":"93_CR42","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.2337\/diabetes.53.9.2250","volume":"53","author":"T Masaki","year":"2004","unstructured":"Masaki T, Chiba S, Yasuda T, Noguchi H, Kakuma T, Watanabe T, Sakata T, Yoshimatsu H (2004) Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 53(9):2250\u20132260","journal-title":"Diabetes"},{"issue":"4 Pt 3","key":"93_CR43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/15622970903079507","volume":"10","author":"T Treuer","year":"2009","unstructured":"Treuer T, Hoffmann VP, Chen AK, Irimia V, Ocampo M, Wang G, Singh P, Holt S (2009) Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study. The World J Biol Psychiatry: Off J World Fed Soc Biol Psychiatry 10(4 Pt 3):729\u2013740. doi: 10.1080\/15622970903079507","journal-title":"The World J Biol Psychiatry: Off J World Fed Soc Biol Psychiatry"},{"issue":"1","key":"93_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-009-1593-5","volume":"206","author":"M Victoriano","year":"2009","unstructured":"Victoriano M, Hermier D, Even PC, Fromentin G, Huneau JF, Tome D, de Beaurepaire R (2009) Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats. Psychopharmacology 206(1):167\u2013176. doi: 10.1007\/s00213-009-1593-5","journal-title":"Psychopharmacology"},{"key":"93_CR45","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1038\/tp.2012.138","volume":"3","author":"V Mondelli","year":"2013","unstructured":"Mondelli V, Anacker C, Vernon AC, Cattaneo A, Natesan S, Modo M, Dazzan P, Kapur S, Pariante CM (2013) Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways. Transl Psychiatry 3:e208. doi: 10.1038\/tp.2012.138","journal-title":"Transl Psychiatry"},{"key":"93_CR46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1192\/bjp.184.1.58","volume":"184","author":"ZJ Zhang","year":"2004","unstructured":"Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP (2004) Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry: J Ment Sci 184:58\u201362","journal-title":"Br J Psychiatry: J Ment Sci"},{"issue":"4","key":"93_CR47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01213011-200504000-00002","volume":"15","author":"LA Templeman","year":"2005","unstructured":"Templeman LA, Reynolds GP, Arranz B, San L (2005) Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 15(4):195\u2013200","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"93_CR48","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/en.2010-0102","volume":"151","author":"SL Gray","year":"2010","unstructured":"Gray SL, Donald C, Jetha A, Covey SD, Kieffer TJ (2010) Hyperinsulinemia precedes insulin resistance in mice lacking pancreatic beta-cell leptin signaling. Endocrinology 151(9):4178\u20134186. doi: 10.1210\/en.2010-0102","journal-title":"Endocrinology"},{"issue":"12","key":"93_CR49","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.metabol.2011.04.008","volume":"60","author":"YH Lee","year":"2011","unstructured":"Lee YH, Magkos F, Mantzoros CS, Kang ES (2011) Effects of leptin and adiponectin on pancreatic beta-cell function. Metabolism 60(12):1664\u20131672. doi: 10.1016\/j.metabol.2011.04.008","journal-title":"Metabolism"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0093-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0093-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:28:28Z","timestamp":1649150908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0093-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0093-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}